Copanlisib for the treatment of adults with relapsed follicular lymphoma
Expert Review of Clinical Pharmacology pp 1-11; doi:10.1080/17512433.2020.1787829
The publisher has not yet granted permission to display this abstract.
Keywords: Treatment / follicular lymphoma / PI3K inhibitor / chemoimmunotherapy / Copanlisib
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Expert Review of Clinical Pharmacology" .